长沙晶易医药

Jingyi Pharma is a leading Chinese Contract Research Organization (CRO) and CDMO specializing in high-end generic drugs and complex formulations. Founded in 2010 and headquartered in Changsha, the company provides integrated services including pharmaceutical R&D, clinical pharmacology, and bioequivalence (BE) testing. They are particularly recognized for their expertise in difficult-to-develop dosage forms, such as topical patches, ophthalmic suspensions, and sustained-release injections. The company operates the Hunan Provincial Engineering Research Center for Topical Drug Delivery Systems, positioning itself as a technical leader in transdermal drug delivery. Jingyi Pharma utilizes a co-development business model, partnering with pharmaceutical manufacturers to navigate the regulatory landscape and bring high-quality medicines to market. With a team of over 600 professionals, the company has supported hundreds of successful NMPA filings and clinical trials.